VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were up 6.9% during trading on Friday . The stock traded as high as C$0.16 and last traded at C$0.16. Approximately 181,550 shares traded hands during trading, an increase of 31% from the average daily volume of 138,994 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Stock Performance
The firm has a market capitalization of C$24.31 million, a PE ratio of -5.17 and a beta of 0.27. The firm has a 50-day moving average price of C$0.19 and a 200 day moving average price of C$0.20. The company has a quick ratio of 6.67, a current ratio of 3.09 and a debt-to-equity ratio of 18.47.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.
- Five stocks we like better than VentriPoint Diagnostics
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 11/6 – 11/10
- How to Invest in the FAANG Stocks
- Data giants MongoDB and Snowflake just got upgraded
- 3 Fintech Stocks With Good 2021 Prospects
- Plug Power at tipping point; it’s make or break time for hydrogen
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.